About
Keya Medical is an international medical technology company based in Beijing, China, with a presence in Seattle, Washington. The company specializes in developing deep learning-based medical devices aimed at cardiovascular diagnosis and treatment. Keya Medical leverages artificial intelligence to provide advanced technologies that address clinical challenges, particularly in non-invasive coronary artery assessment. The flagship product, DEEPVESSEL FFR (DVFFR), is an AI-powered tool for analyzing computed tomography fractional flow reserve. It offers a non-invasive method to assess coronary artery disease and has received multiple regulatory approvals, including FDA clearance and CE marking. Keya Medical is also focused on expanding its research and development pipeline to create a comprehensive suite of solutions that enhance patient care from early screening to post-treatment follow-up. The company collaborates with healthcare organizations and participates in industry events to showcase its innovations.
Technologies
Keywords
Company Information
-
Employees 35
-
Founded 2016
-
Annual Revenue $10000000
Location
107 Spring St, Seattle, Washington, United States, 98104